Latest in Reckitt Benckiser

Sort by

2 items

Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling

A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC
Business - MarketWatch - November 1
Reckitt Shares Surge After Baby Formula Lawsuit Win

Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Business - The Wall Street Journal - November 1

Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling